Sensus Healthcare (NASDAQ:SRTS) Full Year 2024 Results

Key Financial Results

• Revenue: US$41.8m (up 71% from FY 2023).
• Net income: US$6.65m (up by US$6.16m from FY 2023).
• Profit margin: 16% (up from 2.0% in FY 2023). The increase in margin was driven by higher revenue.
• EPS: US$0.41 (up from US$0.03 in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Sensus Healthcare Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 5.6%. Earnings per share (EPS) missed analyst estimates by 4.7%.

In the last 12 months, the only revenue segment was Medical Laser Systems contributing US$41.8m. The largest operating expense was General & Administrative costs, amounting to US$7.15m (40% of total expenses). Explore how SRTS's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Medical Equipment industry in the US.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.